Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
28 Results for "
ILT3
" in MedChemExpress (MCE) Product Catalog:
Products (28)
28 Results for "ILT3" in MCE Product Catalog:
Cat. No.: HY-P990462
Target:
Domaines de recherche:
Cat. No.: HY-P991307
Target:
Domaines de recherche:
Cat. No.: HY-P991308
Target:
Cat. No.: HY-184157
Domaines de recherche:
IB15C is an ILT3 (LILRB4) inhibitor with a human Kd of 0.92 μM. IB15C binds to a specific ILT3 pocket, disrupts ApoE interaction, and interferes with downstream inhibitory signaling pathways. IB15C reduces SHP1 and SHP2 phosphorylation, suppresses pro-inflammatory cytokine secretion, enhances amyloid uptake, and attenuates NF-κB activation. IB15C can be used for the research of alzheimer's disease .
Cat. No.: HY-P704762
Pureté: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-P77738
Pureté: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Species:
Source:
Cat. No.: HY-P705056
Pureté: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-P701065
Pureté: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-P704249
Pureté: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Species:
Source:
Cat. No.: HY-P700780
Pureté: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-P701064
Pureté: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-P700779
Pureté: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-P701018
Pureté: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-184689
CAS No.: 1311892-52-0
ORS-14 is a LILRB4/ILT3 ligand with a Kd of 85.2 nM for human receptors. ORS-14 blocks SCG2-mediated LILRB4 signaling pathway, reverses SCG2-mediated immunosuppression, restores cytokine production, reduces tumor cell viability, recovers cytotoxic T cell function, and increases the frequency of granzyme B + CD8 + T cells. ORS-14 can be used in research related to colorectal cancer and acute myeloid leukemia .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
